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Two distinct, but rapidly converging, areas of research (the
hygiene hypothesis and the study of probiotic/prebiotic
effects) have emphasised the need to understand, and
ultimately to manipulate, our physiological interactions
with commensal flora, and with other transient but
harmless organisms from the environment that affect
immunoregulatory circuits. The story began with allergic
disorders but now inflammatory bowel disease is
increasingly involved.
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EARLY FORMULATIONS OF THE HYGIENE
HYPOTHESIS
The hygiene hypothesis was first proposed in the
late 1980s to explain the rise in allergic condi-
tions (reviewed by Rook and colleagues
1). The
incidence of these disorders in the USA and
Europe increased from the late 19th century, and
appears to have doubled in some decades,
particularly during the 1960s and 1970s.
Epidemiological correlations with the modern
way of life prompted the assumption that
modern hygiene was reducing contact with
pathogens that prime T helper 1 (Th1) responses.
At that time it was believed that this would
result in a compensatory increase in T helper 2
(Th2) activity that characterises allergic disor-
ders. This concept, requiring Th1 inducing infec-
tions to control Th2 mediated allergic conditions,
arose because of the remarkable compartmenta-
lisation of medical knowledge. Readers of this
journal, aware of the simultaneous increase in
several Th1 mediated disorders such as Crohn’s
disease, type 1 diabetes, and multiple sclerosis,
will be sceptical. Indeed, the incidences of
allergic disorders (Th2) and of type 1 diabetes
(Th1) correlate closely both within Europe and
outside.
2
IMMUNOREGULATORY DISORDERS
The unifying hypothesis that can explain the
simultaneous increase in autoimmunity and
inflammatory bowel disease (IBD) (Th1
mediated) and allergies (Th2 mediated) is that
modern living conditions can lead to defective
maturation of regulatory T cells (Treg) and
regulatory antigen presenting cells (APCreg).
Therefore, rather than Th1/Th2 balance, the
crucial factor is likely to be the effector T cells
(Teffector)/Treg balance. In the absence of optimal
levels of immunoregulation, the individual may
develop a Th1 or a Th2 mediated inflammatory
disorder, depending on his/her own particular
Th1/Th2 bias, immunological history, and genetic
background. The argument that a similar lack of
Treg activity could underlie the increases in such
diverse disorders as allergies, IBD, and autoim-
munity is given added weight by the observation
that mice or humans who have genetic defects of
the transcription factor Foxp3, which is required
for some Treg functions, have a syndrome that
includes components of all of these disease types.
Thus diminished immunoregulation can lead to
inappropriate immune responses to allergens,
gut contents, or self (discussed by Rook and
colleagues
1).
TREG DEFECTS IN CHRONIC
INFLAMMATORY DISORDERS
If this reinterpretation of the hygiene hypothesis
is correct, the increase in human immunoregu-
latory disorders is at least partly attributable to
defective Treg activity. Evidence to confirm this
hypothesis has come from studies of allergic
disorders,
3 multiple sclerosis,
4 autoimmune poly-
glandular syndromes,
5 and cow’s milk intoler-
ance.
6 It is likely to be true for IBD too, though
more difficult to prove. The intestine is always in
a state of controlled inflammation, and T cells of
the regulatory phenotype are abundant in the
guts of patients with IBD.
7 Nevertheless, data
from animal models of IBD suggest that the
problem is likely to be an immunoregulatory
one,
8 and there is evidence that there is defective
induction of oral tolerance in IBD patients.
9
Moreover, they have exaggerated responses to
bowel flora
10 which also appear to be the disease
triggering antigens in animal models.
8
MICROBIAL EXPOSURE AND
IMMUNOREGULATION
How does this Treg orientated concept relate to
the original hygiene hypothesis, and why would
microbial exposure affect maturation of regula-
tory pathways? To answer these questions we
must first establish what we mean by hygiene.
One interpretation of the word ‘‘hygiene’’ in
this context, mostly promoted by the media,
assumes that the critical factor is domestic
hygiene (bathing, soaps, detergents, antibacterial
kitchen cutting boards, etc). However, a com-
prehensive recent report has shown that the
development of these practices in the home does
not correlate with the observed changes in the
occurrence of immunoregulatory disorders.
11
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Abbreviations: IBD, inflammatory bowel disease; Th1,
Th2, T helper 1, 2; Teffector, effector T cells, whether Th1 or
Th2; Treg, regulatory T cell; APC, APCreg, antigen
presenting cell/regulatory antigen presenting cell; DC,
dendritic cell; TLR, toll-like receptor; KO, gene knockout;
IL, interleukin; TGF-b, transforming growth factor b
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www.gutjnl.comA second view is that the critical change is the decreased
frequency of infections due to pathogenic organisms. When
the data available from the Centres for Disease Control and
Prevention for the incidence of some infections are plotted
against time, the graphs suggest that some of the decreases
did occur during the critical period 1960–1985 when some
chronic inflammatory disorders were doubling every dec-
ade.
12 However, more detailed analysis of European data
reveals that most of the changes in exposure to pathogens
took place long before the crucial period.
11 In addition, there
is strong epidemiological evidence to suggest that certain
pathogens, such as childhood viruses and respiratory infec-
tions, cause an increase rather than a decrease in the
incidence of allergic disorders.
13 Interestingly, despite the
detrimental effect of infections, this study still identified
protective effects of being sent to day care, keeping pets, and
living on a farm.
13 The latter has been a consistently robust
observation, and the protective effect of exposing children to
cowsheds is well documented.
14 If childhood infections do
not protect and home hygiene does not correlate, what might
be the protective factors associated with pets, farms, and day
care centres?
‘‘Contact with ‘‘old friends’’ is greatly diminished in rich
countries but increased on farms, in cowsheds, and
through contact with pets’’
The answer might lie in certain relatively harmless
microorganisms (including helminths, saprophytic mycobac-
teria, and lactobacilli) that have been present throughout
mammalian evolution. We have called this the ‘‘old friends’’
hypothesis.
1 Contact with ‘‘old friends’’ is greatly diminished
in rich countries but increased on farms, in cowsheds, and
through contact with pets. A number of reports have
provided evidence for this interpretation. Allergic disorders
are less frequent in individuals with helminth infections, and
atopic sensitisation increases after treatment of intestinal
helminths.
15 Similarly, there are less lactobacilli in the guts of
children with allergies,
16 and a preliminary clinical study
suggests that high doses of lactobacilli may inhibit develop-
ment of atopic eczema in genetically high risk children.
17
Finally, the saprophytic mycobacterium M vaccae, originally
isolated, as its name suggests, from a cow shed, potently
drives maturation of Treg that will treat pre-existing allergy in
a mouse model
18 and has given encouraging results in clinical
trials in allergic disorders.
19 20
THE MECHANISM BEHIND THE ‘‘OLD FRIENDS’’
HYPOTHESIS
We suggest that because of our long evolutionary association
with these organisms, they are recognised by the innate
immune system as harmless or, in the case of some
helminths, treated as ‘‘friends’’ because a response would
merely lead to immunopathology (fig 1). Therefore, rather
than priming aggressive immune responses, these organisms
prime immunoregulation.
1 They do it by inducing an unusual
pattern of maturation of dendritic cells (DC)
21 22 such that
these retain the ability to drive Treg. This effect requires the
innate immune system. Toll-like receptor 2 (TLR2) may be
involved for helminths
21 and TLR9 for lactobacilli.
23 It is
interesting that polymorphisms of NOD2 (an intracellular
receptor for bacterial peptidoglycan) are linked to increased
susceptibility to both Crohn’s disease
24 and asthma.
25 Thus an
extension of the ‘‘old friends’’ mechanism suggests that in an
environment that less actively primes Treg activity, immunor-
egulatory disorders will occur first in those individuals whose
innate immune systems are least efficient at driving Treg.
26
BYSTANDER AND SPECIFIC IMMUNOREGULATION
The increased DCreg and Treg induced by ‘‘old friends’’ then
lead to two immunoregulatory mechanisms mediated in part
by release of interleukin (IL)-10 and transforming growth
factor b (TGF-b). Firstly, continuing exposure to ‘‘old
friends’’ will cause continuous background activation of
Treg specific for the ‘‘old friends’’ themselves, resulting in a
constant background of bystander suppression.
‘‘Continuing exposure to ‘‘old friends’’ will cause con-
tinuous background activation of Treg specific for the ‘‘old
friends’’ themselves, resulting in a constant background of
bystander suppression’’
This mechanism has been elegantly demonstrated in a
model of colitis.
27 Secondly, DCreg inevitably sample self, gut
contents, and allergens and so induce Treg specific for the
target antigens of the three groups of chronic inflammatory
disorder. These mechanisms may be aborted when there are
legitimate ‘‘danger’’ signals. For example, Treg function can
be turned off by appropriate ‘‘danger signals’’ in vitro.
28
‘‘OLD FRIENDS’’, THE GUT, AND PROBIOTICS
‘‘Old friends’’ provide a conceptual link between the increase
in allergic disorders, which triggered the formulation of the
hygiene hypothesis, and the simultaneous increase in IBD, as
similar organisms may be involved. For example, Weinstock
et al have reviewed evidence that diminished exposure to
helminths is a critical factor in the increase in IBD. They also
have encouraging clinical results using oral delivery of the
ova of Trichuris suis, which transiently colonises the human
intestine.
29 Similarly, there have been several preliminary
studies of the efficacy of bacterial probiotics, usually derived
from lactobacillus strains, for inducing or maintaining
remission in IBD (reviewed by Sartor
30). This issue was
discussed at a recent meeting of the International Scientific
Association for Probiotics and Prebiotics (ISAPP; http://
www.isapp.net/).
‘‘We hypothesise that in the context of IBD, the property
that matters most is the ability to drive Treg’’
Some of the effects of probiotics are beginning to be
understood at a molecular level and involve striking
mechanisms, including competition for ecological niches
within the gut, inhibition of signalling via nuclear factor
kB, direct antimicrobial effects of secreted components,
modulation of apoptosis, and activation of macrophages that
take part in driving epithelial repair (partly reviewed by
Ghosh and colleagues
31). However, we hypothesise that in the
context of IBD, the property that matters most is the ability to
drive Treg.
PROBIOTICS AND TREG
There is evidence that some probiotics can induce Treg. Orally
administered Lactobacillus casei reduced skin inflammation
due to contact sensitivity in animals sensitised to dinitro-
fluorobenzene.
32 This finding cannot be attributed to the local
gut specific effects of L casei but rather appears to require
CD4+ T cells and is likely to have been mediated by Treg.
Moreover, some strains of lactobacillus mature DC so that
they release little TNF-a or IL-12 but maintain their ability to
release IL-10. This might facilitate induction of Treg.
33 34 In IL-
10 gene knockout (KO) mice, probiotics that attenuate the
colitis to which these animals are susceptible downregulate
Th1 cytokines while maintaining TGF-b.
35 Both oral and
subcutaneous administration promote this effect.
36 This
activity of lactobacilli via the subcutaneous route protects
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collagen arthritis, a mainly Th1 mediated model of auto-
immunity.
36
‘‘The gut may be the major site for Treg induction even
when the probiotic is given subcutaneously’’
The fact that probiotics work in models of colitis and
arthritis, whether given orally or subcutaneously, is evidence
that the important function in this context is not a gut
specific one. Once generated, Tregs can travel to other tissues.
It is interesting however that the gut may be the major site
for Treg induction even when the probiotic is given
subcutaneously. Antigens containing bacterial polysacchar-
ides
37 38 or whole organisms,
39 even when given parenterally,
may evoke a pattern of response, detected as IgA secreting
cells in peripheral blood, that mimics the response to mucosal
immunisation. It seems likely that this is due to cross
reactivity with antigens already experienced by the gut
associated lymphoid tissue. Moreover, induction of IgA in
the gut is heavily dependent on TGF-b which is also closely
involved in the maturation of Treg.
40
CONCLUSIONS
The ‘‘old friends’’ hypothesis has evolved into a concept
similar to that which lies behind attempts to modulate
disease by altering the bowel flora. The strong parallels point
to the following conclusions. Firstly, we suggest that the
strains (whether ‘‘old friends’’ or probiotics; whether bacteria
or helminths) used for clinical trials in disorders of
immunoregulation (allergies, IBD, autoimmunity) ought to
be those which can be shown to drive Treg. Secondly, the
particular organism used might need to be tailored to the
individual patient. The ‘‘old friends’’ mechanism implies that,
in rich countries, we live in an environment that does not
efficiently prime Treg activity. This might precipitate immu-
noregulatory disorders most frequently in those individuals
whose innate immune systems have genetic polymorphisms
that further reduce the efficiency of Treg induction.
26 Clearly,
an immunotherapeutic that requires TLR2 to drive Treg will
not work in an individual in whom this receptor is non-
functional.
Ultimately, the answer must lie in more rigorous proof that
diminishing exposure to these Treg inducing organisms is a
factor in the increase in immunoregulatory disorders. If
confirmed, we will be able to devise subtle changes to our
lifestyles that reconstitute this exposure by the oral route.
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